Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

BACKGROUND: This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Duman, Neval, Uyanik, Abdullah, Unsal, Abdulkadir, Sezer, Siren, Camsari, Taner, Cirit, Mustafa, Yilmaz, Mehmet Emin, Altun, Bülent, Duranay, Murat, Yildiz, Alaattin, Sahin, Idris, Dogukan, Ayhan, Ustundag, Sedat, Karayaylali, Ibrahim, Kahveci, Arzu, Sindel, Sukru, Kiykim, Ahmet Alper, Yenicerioglu, Yavuz, Akbas, Ertugrul, Ozdener, Fatih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257910/
https://www.ncbi.nlm.nih.gov/pubmed/25504109
http://dx.doi.org/10.1093/ckj/sfu079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257910/
https://www.ncbi.nlm.nih.gov/pubmed/25504109
http://dx.doi.org/10.1093/ckj/sfu079

Ejemplares similares